All News

Keytruda plus chemotherapy failed to best the chemotherapy docetaxel alone in patients with metastatic castration-resistant prostate cancer, according to findings of a study of more than 1,000 patients.

Kimberly is a true asset to our patients. She helps them to face the complicated health care system, making sure patients can get all the testing and treatment they need.

As an oncology nurse, which is emotionally taxing and rewarding work, she manages to sprinkle kindness at all times.

I made too many late-night purchases for things that I thought I’d need after my mastectomy. Thankfully, the STOMP group helped me get rid of some of these items.

The Food and Drug Administration approved oral Nubeqa plus the chemotherapy docetaxel for patients with metastatic hormone-sensitive prostate cancer.

The Food and Drug Administration approved Enhertu for the treatment of unresectable or metastatic HER2-low breast cancer — marking the first targeted drug for this newly defined breast cancer subtype.

From the late YouTuber “Technoblade” being honored by the Sarcoma Foundation of America to a country singer making a leukemia survivor’s dreams come true, here’s what’s happening in the cancer space this week.

The tablet version of Calquence, which was approved by the FDA for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia and relapsed/refractory mantle cell lymphoma, may be taken alongside other drugs to reduce gastric-related side effects.

Treatment with Onivyde failed to best the chemotherapy topotecan in improving overall survival in patients with small cell lung cancer whose disease failed to respond to platinum-based first-line treatment, according to findings from a primary analysis of the phase 3 RESILIENT trial.

When my grandmother passed, I noticed my aunt was ruder than usual, and I wondered if I was like that during my cancer experience... and if the pain I was going through excused that behavior.

In this video, an expert discusses which men with prostate cancer are eligible for genetic testing, and what patients can do if they are not eligible but want to undergo testing anyway.

I recently read a book about the psychology of money, and actually related much of the content to my life after osteosarcoma.

Cancer-related pain, especially when severe, is associated with negative effects on patients’ employment and financial status, recent findings showed.

Survivors of childhood cancer had higher rates of infection-related hospitalizations than their healthy peers, at both the five- and 10-year post-treatment mark.

Enrollment has begun on a phase 3 clinical trial assessing the safety and efficacy of an investigational cell therapy in patients with acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndromes.

Findings from a recently published study demonstrated that only a small percentage of women — all with breast cancer — who received silicone breast implants underwent the recommended screening to assess for potential ruptures.

Despite how caring they may be, certain people in our life had a difficult time being there for the realities of my daughter’s cancer experience.

Treatment with primary radiotherapy was linked to an increased risk for the development of secondary primary cancers among a large group of men with localized prostate cancer, according to recent study findings.

The findings add to a growing body of literature that demonstrate coffee and/or tea consumption is not detrimental to breast cancer survivors, according to the study authors.

Losing my hair from breast cancer treatments was an emotional experience for me and helped me empathize with others who also lost their hair.

Patients with cancer are encouraged to learn more about their disease from evidenced-based sources and not “Dr. Google.”

Cancer treatment-related osteoporosis caused me to shrink two inches.

Subcutaneous (injectable) Tecentriq had similar movement throughout the body, while saving on treatment time compared to intravenous administration of the drug in a group of patients with non-small cell lung cancer.

The FDA will allow the study of CYAD-101, a novel CAR-T cell therapy, to continue in patients with metastatic colorectal cancer now that the eligibility criteria for the trial has been amended.

Shrinking liver cancer tumors helps patients become eligible for transplant, thus improving their long-term outcomes, according to recent study results.

After being diagnosed with cancer, hope can be a very fragile thing, but it is essential that we hold on to it.

TAVT-45, an easy-to-swallow drug that can be suspended in water or juice, is being studied for the treatment of patients with metastatic prostate cancer.

In honor of World Lung Cancer Day, CURE® compiled the five most-read lung cancer-related news items from 2022 that patients may have missed.

I felt her authenticity and her genuine care for me. I felt safe.